Multi-polygenic score approach to trait prediction by Krapohl, E et al.
OPEN
ORIGINAL ARTICLE
Multi-polygenic score approach to trait prediction
E Krapohl1, H Patel2,3, S Newhouse2,3,4, CJ Curtis1,2, S von Stumm5, PS Dale6, D Zabaneh1, G Breen1,2, PF O’Reilly1 and R Plomin1
A primary goal of polygenic scores, which aggregate the effects of thousands of trait-associated DNA variants discovered in
genome-wide association studies (GWASs), is to estimate individual-speciﬁc genetic propensities and predict outcomes. This is
typically achieved using a single polygenic score, but here we use a multi-polygenic score (MPS) approach to increase predictive
power by exploiting the joint power of multiple discovery GWASs, without assumptions about the relationships among predictors.
We used summary statistics of 81 well-powered GWASs of cognitive, medical and anthropometric traits to predict three core
developmental outcomes in our independent target sample: educational achievement, body mass index (BMI) and general
cognitive ability. We used regularized regression with repeated cross-validation to select from and estimate contributions of 81
polygenic scores in a UK representative sample of 6710 unrelated adolescents. The MPS approach predicted 10.9% variance in
educational achievement, 4.8% in general cognitive ability and 5.4% in BMI in an independent test set, predicting 1.1%, 1.1%, and
1.6% more variance than the best single-score predictions. As other relevant GWA analyses are reported, they can be incorporated
in MPS models to maximize phenotype prediction. The MPS approach should be useful in research with modest sample sizes to
investigate developmental, multivariate and gene–environment interplay issues and, eventually, in clinical settings to predict and
prevent problems using personalized interventions.
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INTRODUCTION
Genome-wide association studies (GWASs) have been successful
in identifying thousands of associations for hundreds of complex
traits and common disorders.1 One use of GWAS results is to
understand biological pathways between genotypes and pheno-
types. Another use, the focus of the present research, is to
estimate genetic propensities of individuals to predict individuals’
future problems and potential and, eventually, to develop
personalized interventions that meet individual medical, psychia-
tric and educational needs. Both goals have been hindered by the
ubiquitous GWA ﬁnding that the largest effect sizes are extremely
small.2 For example, the largest population effect sizes found for
common variants in height or body mass index (BMI) account for
only ~1% of the variance.3,4 We know empirically that the vast
majority of common genetic variants for most traits have a
markedly lower effect than 1%.2
The highly polygenic nature of complex traits and common
disorders poses an immense challenge for understanding the
biological mechanisms linking single variants with phenotypes.
However, when the priority is phenotypic prediction, polygenic
scores can be used to aggregate the effects of many DNA variants
in order to investigate their joint predictive power.5,6 Rather than
just using single-nucleotide polymorphisms (SNPs) that reach
genome-wide signiﬁcance, a recent development is to aggregate
a much larger number of SNPs, weighted by their GWA effect size
estimate, as long as together they increase the prediction in an
independent sample, even if some SNPs have no real effect.7 For
example, for height, a polygenic score that aggregates the effects
of ~2000 SNPs accounts for 21% of the variance of height in
independent samples.3
The other deﬁning characteristic of complex traits and common
disorders is the abundance of genetic correlations between them.
There is consistent evidence for genetic correlations between
psychiatric disorders, between anthropometric traits and between
educational and cognitive traits, as well as for genetic correlations
across these categories.8–11
Genetic correlation can arise from pleiotropy, the phenomenon
of multiple traits being associated with the same gene or genetic
variant.8 Genetic correlation can also reﬂect shared biological
pathways or more indirect linkage.12 Regardless of its cause,
genetic correlation between different traits means that a
polygenic score based on one trait can predict a different
outcome trait, with predictive accuracy a function of the shared
genetic signal between them. Therefore, when the aim is
prediction, genetic correlation can be exploited for trait prediction
while remaining agnostic to the underlying mechanisms.
A primary goal of polygenic scores, which aggregate the effects
of thousands of trait-associated genetic variants discovered in
GWAS, is to estimate individual-speciﬁc genetic propensities. This
is typically achieved using a single polygenic score, but here we
use an approach to increase predictive power by exploiting the
joint power of multiple discovery GWASs. We use a multi-
polygenic score (MPS) approach that exploits genetic correlations
between the outcome trait and a multitude of traits by using the
joint predictive power of multiple polygenic scores in one
regression model.
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We selected GWASs from a centralized repository of summary
statistics—based on their statistical power and regardless of prior
evidence for association with the outcomes—to predict three core
developmental outcomes in our independent target sample:
educational achievement, BMI, and general cognitive ability. Using
repeated cross-validation, we trained and validated the prediction
models using elastic net regularized regression, a multiple
regression model suited to deal with a large number of correlated
predictors while preventing overﬁtting.13 We subsequently tested
how well these models predict outcomes in an independent
test set.
Here, we employ a MPS approach that uses publicly available
GWAS summary statistics to estimate individual-level genetic
propensities and predict developmental outcomes in an indepen-
dent target sample. This stands in contrast to multi-trait
approaches that rely on access to individual-level data in the
discovery data sets because they make use of a method from
animal breeding in which the total genetic effect (‘breeding
value’) of each individual in a discovery data set is estimated from
the best linear unbiased predictor in a multi-trait random-effects
model that can be used for individual-level prediction in the
validation data sets. These multi-trait methods are not applicable
to GWAS summary statistics when genotype data are unavailable
because of privacy or logistical constraints that are frequently
the case.
The declared aim of the current MPS approach is to maximize
prediction of developmental outcomes, rather than investigating
their etiology. This stands in contrast to multi-trait meta-analytic
approaches of GWAS summary statistics that relies on substantial
and consistent correlations between discovery GWASs and whose
main aim is variant discovery.14–17 The current MPS approach
allows for, but does not require, correlation among polygenic
predictors.
MATERIALS AND METHODS
Sample
The target sample comprised genome-wide SNP and phenotypic data from
6710 unrelated adolescents drawn from the UK representative Twins Early
Development Study (TEDS). TEDS is a multivariate longitudinal study that
recruited over 11 000 twin pairs born in England and Wales in 1994, 1995
and 1996. Both the overall TEDS sample and the genotyped subsample
have been shown to be representative of the UK population.18–20 The
project received approval from the Institute of Psychiatry ethics committee
(05/Q0706/228) and parental consent was obtained before data collection.
We processed the genotypes for the 6710 individuals using stringent
quality control procedures followed by imputation of SNPs using the
Haplotype Reference Consortium reference panel21 (Supplementary
Methods S1).
Predictors
Discovery data sets: GWAS summary statistics. We selected GWAS
summary statistics from LD hub, a centralized repository for summary
statistics22 based on their statistical power—regardless of prior evidence
for association with our outcome traits. Speciﬁcally, we included 81 GWAS
summary statistics that were either publically downloadable or obtained
via correspondence and had a linkage disequilibrium (LD) score23
heritability z-score 45, indexing good statistical power (which is a
function of variance explained and sample size). Supplementary Table S1
provides details of all GWAS summary statistics included in our analyses.
The published version of the child IQ GWAS included the present
target sample of TEDS. Therefore, to avoid bias, the present analyses
used summary statistics from a rerun of the GWAS meta-analysis
excluding TEDS.
Polygenic scores. We created 81 genome-wide polygenic scores for each
of the 6710 individuals in the TEDS sample using summary statistics from
the GWAS described above (Supplementary Table S1). After quality control
(Supplementary Methods S1), the study data included 7 581 516 geno-
typed or well-imputed (info 40.70) SNPs. These were quality controlled
and coordinated with each of the summary statistics, respectively, by
excluding markers due to nucleotide inconsistencies or low minor allele
frequency (o1%). Number of markers before and after quality control and
coordination with the study data are listed in Supplementary Table S1.
We constructed polygenic scores as the weighted sums of each
individual’s trait-associated alleles across all SNPs. We used LDpred24 to
construct the scores. LDpred uses a prior on the markers’ effect sizes and
adjusts summary statistics for LD between markers. Scores were
standardized and adjusted for 30 principal components. More details on
the construction of the polygenic scores are provided in Supplementary
Methods S2.
Outcomes
To illustrate the MPS approach, we selected three key developmental
outcomes:
Educational achievement operationalized as the mean grade of the
three compulsory subjects (Mathematics, English and Science) attained on
the standardized United Kingdom General Certiﬁcate of Secondary
Education (GCSE), taken by almost all (499%) pupils at the end of
compulsory education at age 16 years.
General cognitive ability at age 12 years assessed by two verbal and two
nonverbal cognitive standardized tests.
BMI at age 9 years that was age and sex adjusted using external
reference data.
Supplementary Methods S3 and Figure S1 contain detailed descriptions
of the three measures.
Models
Single-polygenic score models. To estimate the separate prediction of each
predictor, we ﬁt a series of simple linear regression models for each of the
81 polygenic scores and each of the 3 outcomes. For each GWAS-outcome
combination, three models were run using polygenic scores created with
Gaussian mixture weights of 1, 0.1 and 0.01, respectively. The model that
explained the most variance in the outcome (that is, largest cross-validated
R2 in training data) was then entered into the multi-score model. These
simple linear regression models were ﬁt and validated in repeated 10-fold
cross-validation (see section below for details) using the lm function
implemented within the caret R package.25 Based on consistent evidence
for extensive genetic correlations across complex traits and disorders,
rather than summing up, the predictions of the single-score models were
expected to substantially overlap.
MPS models. We used the MPS model to estimate the joint prediction of
the 81 polygenic scores as well as the ranking of predictors by the
magnitude of their contribution to predicting the outcome.
Conventional multiple linear regression models in the presence of a
large number of predictors are subject to overﬁtting, and stepwise regres-
sion suffers from upward-biased coefﬁcients and R2 (see, for example,
Tibshirani26). We used elastic net regularized regression13 to predict
outcomes and by selecting predictors and estimating their contribution to
the prediction. Regularized regression models are general linear models
that employ strict penalties to prevent overﬁtting. Elastic net allows for
estimating the joint predictive ability of a large number of variables while
preventing overﬁtting. Elastic net uses a linear combination of two
regularization techniques, L2 regularization (used in ridge regression) and
L1 regularization (used in LASSO (least absolute shrinkage and selection
operator)) by simultaneously implementing variable selection (that is,
dropping/retaining variables) and continuous shrinkage (that is, penalizing
coefﬁcients for overﬁtting); and it efﬁciently deals with multicollinearity by
selecting or dropping groups of correlated variables.13,27
Elastic net overcomes the limitation of LASSO that tends to select one
variable from a group of correlated predictors and to ignore the others. In
situations where predictors are non-independent or correlated (for
example, sharing genetic signal or discovery cohorts) the elastic net has
the advantage of including automatically all the highly correlated variables
in the group (grouping effect).13,27,28
Final model coefﬁcients are analogous to a conventional multiple linear
regression output that allows for a ranking of predictors by the magnitude
of their contribution to predicting the outcome. Overall variance explained
by the model is indexed by the coefﬁcient of determination, R2.
We used glmnet R package15–17 implemented within caret R package25
to conduct a series of linear elastic net regularized regressions and select
polygenic predictors leading to an optimized ﬁnal model for each
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outcome. Elastic net regularized regression employs two hyperparameters,
alpha and lambda.13 As recommended to achieve optimized balance
between variance explained and minimum bias, we ﬁt models to tune over
both alpha and lambda parameter values in repeated 10-fold cross-
validation.29.
Model training and testing
Generally, a predictive model is considered powerful when the model is
capable of predicting outcomes in ‘unseen’ data with high accuracy. The
performance of a model can therefore be evaluated by testing how well it
predicts phenotypes of individuals whose data were not included in the
construction of the prediction model.
Each model described in the preceding section was trained and tested
using the following three-step strategy:
Data splitting. We randomly split the data set into a separate training set
and test set (60% train, 40% test).
Model training. We used repeated cross-validation on the training set to
train and optimize the model via validation.
Model testing and comparison. We applied the ﬁnal model to the
independent test set to obtain an unbiased estimate of model
performance.
Model training. The training set was used to train and validate the model,
this included hyperparameter tuning for the elastic net models. In order to
optimize the balance between variance explained and minimum bias, we
tested each model in 10-fold cross-validation with resampling.29 We split
the training data randomly into 10 equal-sized subsets, using 9 subsets to
train the model and the remaining subset as validation. The cross-
validation process was repeated 10 times, with each of the 10 subsamples
used once as the validation data.
Although cross-validation has been shown to produce nearly unbiased
estimates of accuracy, variability of these estimates can be reduced by
bootstrap methods, wherein available data are repeatedly sampled with
replacement in order to mimic the drawing of future random
sampling.30,31 Therefore, to minimize variation across validation data sets,
we repeated the 10-fold cross-validation 100 times with random data set
partitions.32
The optimized or ‘ﬁnal’ model is chosen based on the largest
performance value (or smallest mean squared error). Predictors retained
within the model and standardized coefﬁcients index whether, and to
what extent, they contribute to predicting the outcome. Model
performance for the repeated cross-validation in the training set was
summarized as mean-cv-R2train from the resampling distribution.
Model testing and comparison. To obtain unbiased estimates of
model performance, we used the parameters from the ﬁnal model
obtained from the repeated cross-validation in the training set to predict
outcomes (that is, educational achievement, BMI and general cognitive
ability) in the independent test set. To index prediction accuracy, we used
the coefﬁcient of determination, in the following referred to as R2test.
Differences between mean-cv-R2train and R
2
test provide an index of out-of-
sample error.
We used permutation to test the statistical signiﬁcance of the difference
in predictions between the MPS and the best single-score model. To test
the null hypothesis of exchangeability of models, H0: MPSR
2
test = best-single-
scoreR
2
test, we compared the observed diffR
2
test (MPSR
2
test – best-single-scoreR
2
test)
against an empirical null distribution of no difference in predictions
between the MPS and the best single-score model. We tested the
exchangeability of models by randomly selecting either the MPS or the
best single-score model to generate predictions. We then calculated the
difference in R2 for two models with shufﬂed predictions. The process was
repeated 100 000 times, generating an empirical null distribution of diffR
2
under exchangeability of model predictions.
If the null hypothesis of no difference between models is true,
it would not matter if we randomly exchange the model used for
generating predictions. However, if the observed diffR
2
test value falls outside
of those obtained when randomly exchanging models, this represents
evidence against the null hypothesis of no difference in prediction
between models. The statistical signiﬁcance, as expressed in an
empirical P-value, is calculated as the fraction of permutation values that
are at least as extreme as the original diffR
2
test statistic observed in
nonpermuted data.
RESULTS
MPS predictions
The MPS models showed better prediction in the independent
test set than the best single-score models. The best single-score
models were the large 2016 GWAS of years of education
predicting 9.8% of the variance in educational achievement and
3.6% in general cognitive ability in the test set. For BMI, Obesity
class 1 achieved the best single-score prediction, explaining 3.8%
of the variance. (See Supplementary Table S2 for full single-score
models results; see Supplementary Figure S2 for a visual overview
of the single-score model results.) The MPS models explained
10.9% variance in educational achievement, 4.8% in cognitive
ability and 5.4% in BMI in the test set. The improvement in
variance explained compared with the best single-score models
was 1.1% (P= 4e− 03), 1.1% (P= 2e− 03) and 1.6% (P= 1e− 04),
respectively.
Figures 1a–c show the polygenic predictors selected during
training of the MPS models and their standardized coefﬁcients.
The ranking of predictors provides an index for their contributions
to prediction. Analogous to conventional multiple regression, a
standardized coefﬁcient represents the contribution of the
predictor to the outcome when adjusting for all other variables
in the model.
The model predicting educational achievement retained 12
polygenic predictors (Figure 1a). Cognitive and socioeconomic
polygenic scores took the top ranks. However, the psychiatric
cross-disorder polygenic score, which aggregates genetic risk for
bipolar disorder, schizophrenia, major depressive disorder, autism
and attention deﬁcit hyperactivity disorder, and the score for
depressive symptoms in the general population were also
retained by the model. The scores for Homeostasis Model
Assessment of β-cell function, an index of β-cell function, and
for coronary artery disease also contributed to prediction of
educational achievement.
The MPS model predicting cognitive ability selected 10
polygenic scores during cross-validation (Figure 1b). The strongest
contributions to prediction came from cognitive and socio-
economic variables. Contributions from the psychiatric realm
came from major depressive disorder, autism spectrum disorder
and bipolar disorder, with the latter two having positive
association with cognitive ability.
The MPS model predicting BMI retained 28 polygenic scores
(Figure 1c). The top three strongest predictions came from
obesity-related variables. Ranks four and ﬁve were taken by
coronary artery disease and age at menarche (negative associa-
tion). The sixth strongest predictor for children’s BMI was the
polygenic score based on the GWAS of mean caudate nucleus
volume that plays a role in various non-motor functions including
procedural and associative learning and inhibitory action
control.33–36 Other predictors included ulcerative colitis, leptin
and neuroticism.
Stratiﬁcation by MPS
We examined the phenotypic values by quantile of the MPS
distribution. Figures 2a–c plot the observed outcomes against the
predictions by the MPS model in the test set. In general, the
quantile results were roughly linear.
Figure 2a shows quantile results for mean exam grades.
Individuals in the top 10% of the MPS distribution on average
achieved an ‘A’ mean grade (across the three subjects Mathe-
matics, English and Science), whereas individuals in the bottom
10% MPS distribution achieved a ‘C’ mean grade on average (top
10% mean= 9.74; bottom 10% mean= 8.33 (11 =A*,10 =A, 9 = B,
8 = C, 7 =D, 6 = E, 5 = F, 4 =G, 0 = failed). Cohen’s d was 1.20 (95%
conﬁdence interval 0.99–1.41) suggesting that 88% of the top 10%
MPS group had a mean grade above that of the bottom 10%
group, and there is an 80% probability that a person picked at
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random from the top 10% MPS group will have a higher score
than a person picked at random from the bottom 10% group.37,38
For cognitive ability, Figure 2b illustrates that individuals in the
top 10% of the MPS distribution on average had a standardized
cognitive ability score over 0.64 (95% conﬁdence interval 0.40–
0.89) s.d. higher than those in the bottom 10% MPS distribution.
This means that 74% in the top 10% MPS group had mean ability
score above that of the bottom 10% group, and that there is a
0.00 0.05 0.10 0.15 0.20
Standardized coefficient of polygenic predictors
selected via repeated cross validation in training set
Multi polygenic sore model:
predicting educational achievement
0.00 0.05 0.10 0.15 0.20
Standardized coefficient of polygenic predictors
selected via repeated cross validation in training set
Multi polygenic sore model:
predicting cognitive ability
0.00 0.05 0.10 0.15 0.20
Standardized coefficient of polygenic predictors
selected via repeated cross validation in training set
Multi polygenic sore model:
predicting body mass index
Figure 1. (a) Multi-polygenic score (MPS) model predicting educational achievement. Standardized coefﬁcients of polygenic predictors
selected by elastic net via repeated cross-validation in training set. Analogous to conventional multiple regression, a standardized coefﬁcient
represents the contribution of the predictor to the outcome when adjusting for all other variables in the model. The mean variance explained
of the resampling distribution from the cross-validation was mean-cv-R2train= 0.12. The out-of-sample prediction of the model was R
2
test= 0.109.
(b) MPS model predicting general cognitive ability. Standardized coefﬁcients of polygenic predictors selected by elastic net via repeated cross-
validation in training set. Analogous to conventional multiple regression, a standardized coefﬁcient represents the contribution of the
predictor to the outcome when adjusting for all other variables in the model. The mean variance explained of the resampling distribution
from the cross-validation was mean-cv-R2train= 0.051. The out-of-sample prediction of the model was R
2
test= 0.048. (c) MPS model predicting
body mass index (BMI). Standardized coefﬁcients of polygenic predictors selected by elastic net via repeated cross-validation in training set.
Analogous to conventional multiple regression, a standardized coefﬁcient represents the contribution of the predictor to the outcome when
adjusting for all other variables in the model. The mean variance explained of the resampling distribution from the cross-validation was mean-
cv-R2train= 0.074. The out-of-sample prediction of the model was R
2
test= 0.054.
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67% probability that a person picked at random from the top 10%
MPS group will have a higher score than a person picked at
random from the bottom 10% group.
For BMI, Figure 2c shows that children in the top 10% of the
MPS distribution on average had a 0.80 (95% conﬁdence interval
0.57–1.03) s.d. higher than those in the bottom 10% MPS
distribution. Expressed differently, 79% of children in the top
10% MPS group had a mean ability score above that of the
bottom 10% group, and that there is a 71% probability that a
person picked at random from the top 10% MPS group will have a
higher score than a person picked at random from the bottom
10% group.
DISCUSSION
We demonstrate that the MPS approach that combines summary-
level GWAS data from multiple traits yields better individual-level
phenotype prediction than single-score predictor models in
independent test data.
The observation that a multitude of polygenic scores contribute
to trait prediction in the MPS models highlights the complexity of
the system being studied and the somewhat arbitrary way we
divide it into phenotypic characteristics. We show that polygenic
variation associated with traits other than the to-be-predicted
outcome contributes to prediction. For instance, although there is
a known association between ulcerative colitis and BMI,39 genetic
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Figure 2. (a) Educational achievement by multi-polygenic score (MPS) deciles. Observed mean grade (across the three subjects Mathematics,
English and Science) by deciles of the MPS predictions in the test set. Bars represent 95% conﬁdence estimates. (b) General cognitive ability by
MPS deciles. Observed mean standardized general cognitive ability by deciles of the MPS predictions in the test set. Bars represent 95%
conﬁdence estimates. (c) Body mass index (BMI) by MPS deciles. Observed mean standardized BMI (age and sex adjusted by external
reference) by deciles of the MPS predictions in the test set. Bars represent 95% conﬁdence estimates.
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variants associated with ulcerative colitis are not typically included
in models estimating individuals’ genetic risk for increased BMI.
The predictors selected and coefﬁcients estimated by the MPS
models in the current study can be used to generate individual-
speciﬁc composite estimates of genetic propensities in other and
smaller samples. For a more parsimonious replication, future
research in other samples could construct a simple multiple
regression model using the top ﬁve predictors selected by the
current analyses. The predictive power of such an MPS model can
then be compared with that of the best single-score model. More
generally, in addition to the likely improvement in MPS prediction
as more and larger GWASs are being published, the MPS approach
has the potential to be applied to a wide range of outcomes and
samples, including psychiatric and medical outcomes in case–
control samples.
The predictive power of a polygenic score is not only a function
of the genetic correlation between discovery and outcome trait,
but also of the statistical power present in the discovery GWAS on
which it is based (that is, variance explained and sample size).5 The
MPS approach exploits the fact that even GWASs of genetically
distantly related traits might contribute predictive power if their
power is superior to GWASs of more proximal traits. For instance,
most likely because of its much greater sample size, the years of
education polygenic score predicted general cognitive ability
better than any of the polygenic scores based on GWASs directly
measuring general cognitive ability.
Because predictive power of polygenic scores does not simply
reﬂect the genetic correlation between discovery and target trait,
but depends on the genetic architecture of both traits and sample
size (especially of the discovery sample),5,6,40 the MPS approach is
not suited for investigating etiology. Other methods have been
developed to that end. For instance, multivariate twin studies are
appropriate for investigating trait etiology, or multi-trait GWAS
meta-analysis aims to disentangle effects of correlated traits at the
level of genetic variants.15,16,41–45 In contrast, the declared aim of
the MPS approach is to maximize trait prediction, without
assumptions about the relationships among predictors.
The MPS approach will be useful whenever trait prediction is a
priority. The primary reason for maximizing predictive power
using the MPS approach is to predict phenotypes of individuals
with as much accuracy as possible. Individual-speciﬁc genetic
predictions will be useful in research with modest sample sizes to
investigate developmental, multivariate and gene–environment
interplay issues. Eventually, MPS models could be useful in both
society and science to estimate genetic potential as well as risk in
relation to all domains of functioning, including cognitive abilities
and disabilities, personality and health and illness.
This predictive power will raise concerns about potential early,
even prenatal, prediction. It is important to begin discussions that
are informed by the empirical data because genotype-based trait
prediction is moving towards the point of practical relevance.
Although concerns are warranted, these might be outweighed by
the beneﬁts that could result from being able to predict problems
and potential early and develop stratiﬁed preventions and
interventions accordingly.
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